Skip to content

Insider · CIK 0001994805

Edwards Larry Todd

officer

Files at ARQT (Arcutis Biotherapeutics, Inc.). First filing Dec 3, 2024, latest Dec 3, 2024.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
1 / 0
$7,767 bought, $0 sold

Signals

This insider’s open-market buys and sells, scored.

ScoreSideCompanyValueSharesHoldings changePrice contextFiled
10WeakbuyARQT
Arcutis Biotherapeutics, Inc.
$7,7671,093+1%-

Transactions

Every row this insider has filed, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Nov 30, 2024ARQT
Arcutis Biotherapeutics, Inc.
POpen-market purchase
Common Stock
+1,093$7.11$7,767137,728Dec 3, 2024

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.